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Signal recognition particle (SRP) interacts with the signal sequence in nascent secretory and membrane proteins and directs them to the membrane 
of the endoplasmic reticulum. Membrane targeting is mediated by the 68 and the 72 kDa proteins of SRP. We have cloned and sequenced cDNA 
encoding the 68 kDa protein of canine signal recognition particle (SRP68). SRP68 is a basic protein comprised of 622 amino acid residues. Close 
to the amino terminus there is a glycine-rich region which SRP68 has in common with some RNA-binding proteins. SRP68 shares no detectable 
similarity to any of the proteins in data libraries. 
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1. INTRODUCTION 
The signal recognition particle (SRP) is a small 
ribonucleoprotein particle that is involved in the 
targeting of presecretory and membrane proteins to the 
endoplasmic reticulum (ER) membrane [ 1,2]. During 
the targeting SRP interacts with the signal sequence of 
nascent preproteins and arrests their further elongation 
[3,4]. Elongation resumes after SRP has made contact 
with the docking protein (DP) or SRP receptor in the 
ER membrane [5,6]. The nascent polypeptide is then 
translocated across the membrane. Thus at least three 
different functions of SRP can be distinguished: (i) in- 
teraction with the signal sequence, (ii) translation arrest 
and (iii) interaction with the DP at the ER membrane. 
Structural components in SRP that are involved in these 
three functions have been identified. SRP consists of 
one molecule of 7s RNA (SRP7S or 7SL) and 6 dif- 
ferent polypeptides of 9, 14, 19, 54, 68, and 72 kDa [7]. 
SRP9 and SRP14 can be released from the particle as a 
heterodimeric omplex [8,9]. Their presence in the par- 
ticle is required for the elongation arrest function 
[ 10,111. SRP19 directly contacts the RNA and its 
presence is required for the binding of SRP54 to the 
particle [ 1 , 1 1,121. Crosslinking experiments have 
shown that SRP54 interacts with the signal sequence of 
nascent polypeptides [ 13,141. The SRP68 and SRP72 
proteins form a heterodimeric complex (SRP68/72) 
which interacts with the central rod of SRP7S RNA 
[15]. Inactivation of SRP68/72 by alkylation with N- 
ethylmaleimide leads to a SRP that has lost the ability 
to promote translocation but which can still arrest 
elongation [l ,111. Thus SRP68/72 might directly in- 
teract with the DP in the ER membrane [l 11. Protease 
mapping studies revealed that a 55 kDa domain of 
SRP72 could be liberated from the particle whereas no 
detectable fragment of SRP68 was found to be released. 
It was therefore suggested that SRP68 interacts with the 
RNA while SRP72 is linked to the particle through its 
interaction with SRP68 [9]. 
In order to further characterize the structure and 
function of the SRP68/72 complex we have isolated the 
cDNA encoding SRP68. 
2. MATERIALS AND METHODS 
2.1. Purification and sequence analysis of SRP68 
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SRP was purified from canine pancreas [9] and the 6 proteins of 
SRP were separated on a SDS polyacrylamide gel. The band cor- 
responding to the SRP68 protein (approximately 400 pmol) was excis- 
ed from the gel, cut into pieces and incubated in water for 16 h with 
frequent changes. The washed gel pieces were then immersed in 0.1 M 
ammonium hydrogen carbonate pH 8.0 containing trypsin at a 1:3 en- 
zyme to protein ratio. Following incubation at 37°C for 3 h the 
generated protein fragments were eluted from the gel by shaking the 
pieces twice for 3 h in 0.1% trifluoroacetic acid. Residual water and 
peptide were extracted from the gel matrix by treatment with 
acetonitrile. The eluates were combined, concentrated and extracted 
twice with a 1:4 mixture of isomayl alkohol/heptane [16] to remove 
traces of SDS. Separation of the tryptic peptides was performed by 
reversed phase HPLC (high-performance liquid chromatography) on 
a Vydac 218TP5 column (1.6 x 250 mm). The peptides were sequenc- 
ed in a gas phase sequencer[33]. 
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2.2. Library construction 
Poly (A)+ RNA was prepared from MDCK cells by standard techni- 
ques [17]. cDNA was synthesized by oligo dT priming and cloned 
essentially as described [18], with the fdllowing modifications: 
The adaptors used for the ligation of the cDNA into the vector had 
the following sequence (encoded amino acids are shown below in 
italics): 
(Barn HI) Kpn I Sph I Not I 
GA.TCC.GGT.ACC.AGC.ATG.CGG.CCG.C 
G.CCA.TGG.TCG.TAC.GCC.GGC.G 
G T S M R P 
The presence of a Not1 site immediately adjacent to the cDNA in- 
sert is advantageous for excising large inserts as a single fragment. 
The cloning vector pTEX was constructed by cloning a double 
stranded oligonucleotide encoding the bacteriophage T7 promoter 
and 3 restriction sites (5 ‘-XhoI, EcoRI, SmaI-3’) into the SmaI-site 
of pUEX1 [19]. The restriction enzyme sites in pTEX are in the same 
reading frame as in pUEX 1 between the BarnHI and the Hind111 
sites. This vector allows the expression of a ,&galactosidase fusion 
protein under the control of the lambda PR promoter in E. coli, or the 
synthesis of transcripts from the T7 promoter in vitro. The latter may 
be used for in vitro expression of a cloned cDNA without the 
amino(N)-terminal portion of /3-galactosidase. The library thus ob- 
tained consisted of approx. 450 000 independent clones. 
2.3. Isolation and sequencing of SRP68 cDNA clones 
Approximately 300 000 colonies were screened by colony hybridiza- 
tion [17]. Two degenerate oligonucleotides derived from the amino 
acid sequences of two different tryptic peptides (peptide 1: ala-phe- 
thr-glu-glu-gln-ala-val-leu-tyr-asn-gln; peptide 2: tyr-glu-ala-tyr-asn- 
ile-gly-asp-gln) were end-labeled using polynucleotide kinase to a 
specific activity of lo9 cpm/,ug. Filters were hybridized over night with 
a mixture of both oligos at lo6 cpm/ml in 6 x SSC, 5 x Denhardt’s, 
0.1% SDS at 42°C. After washing in 1 x SSC, 0.1% SDS at 42°C the 
filters were exposed to Kodak XAR film for 4 h at - 70°C. Positive 
colonies were picked and rescreened separately with both 
oligonucleotide probes. Plasmid DNA was prepared from clones 
hybridizing with both probes and one insert sequenced using the Se- 
quenase kit (USB, Cleveland, OH, USA). Using the insert DNA from 
one of the identified clones the library was rescreened and 25 more 
clones identified (pTEX-SRP68-II. 1 to 25) The 5 ‘ends of the longest 
cDNA clones (6, 13, 15 and 23) were sequenced. 
2.4. Subcloning into pGEA4 vectors 
pTEX-SRP68-11.6, -11.13, -11.15 and II.23 were cut with NotI, the 
inserts isolated and the ends filled in with Klenow enzyme. pGEM 3 
and 4 plasmids (Promega, Madison, WI, USA) were cut with XbaI, 
phosphatase treated and overhangs filled in with Klenow enzyme. In- 
serts and vectors were ligated and orientations of the inserts determin- 
ed by restriction enzyme analysis. 
2.5. Transcription/translaCon and imtnunoprecipitation 
pGEM plasmids containing inserts SRP68-11.6, -11.13, II.15 or 
II.23 were transcribed with either SP6 or T7 RNA polymerase [20] 
and the transcripts translated in the wheat germ cell-free system [21] 
and where indicated immunoprecipitated with an anti SRP68 an- 
tibody [9]. An aliquot of the translation mixture or the immuno- 
precipitate was separated by SDS-PAGE and labeled proteins 
visualized by autoradiography. 
2.6. Northern blot analysis 
Cytoplasmic poly(A)+ RNA of MDCK cells and ribosomal RNA of 
canine pancreas and E. coli were separated on a 1% agarose- 
formaldehyde gel and transferred to gene screen plus membrane 
(NEN) 1171. The Not1 insert fragment of pTEX-SRP68-II.6 was 
labelled by random priming and hybridized according to Church and 
Gilbert [22]. Filters were washed at 65°C in 1 mM EDTA, 40 mM 
104 
NaHP04 (pH 7.2) and 1% SDS. Ribosomal RNA from dog pancreas 
and from E. coli was used to calculate the approximate size of SRP68 
mRNA (ribosomal RNAs: 28 S: 4800 bases (b), 18 S: 1900 b, 23 S: 
2900 b, 16 S: 1540 b). 
3. RESULTS 
3.1. Sequence of SRP68 
Canine SRP68 and tryptic fragments of it were 
isolated (see section 2) and subjected to N-terminal se- 
quence analysis. No sequence was obtained from intact 
SRP68 suggesting that its N-terminus is not accessible 
for the chemical degradation used in the sequence 
analysis. Several peptide sequences of SRP68 fragments 
were obtained. Based on the amino acid sequences of 
two of these peptides degenerate oligonucleotides were 
designed and used to screen a MDCK (Madin Darby 
Canine Kidney) cell cDNA library (see section 2). One 
clone hybridized to both oligonucleotides and the insert 
in this clone was therefore used to rescreen the library. 
25 more positive clones were found. The cDNA insert in 
one of these clones (pTEX-SRP68-11.6) was sequenced. 
A schematic outline of pTEX-SRP68-II.6 is shown in 
Fig. 1A and the sequence of the cDNA insert in Fig.lB. 
It comprises 2485 bp and has one large open reading 
frame encoding 622 amino acid residues and one small 
open reading frame close to the polyA tail in the 3 ’ end. 
The calculated Mr of the protein encoded by the large 
open reading frame is 70.2 kDa and thus in good agree- 
ment with the apparent MW of 68 kDa as deduced for 
SRP68 from SDS-PAGE. The amino acid sequences of 
7 peptides of the SRP68 had been determined by se- 
quence analysis. The sequences of these peptides could 
be identified in the amino acid sequence deduced from 
the cDNA (Fig. 1B) showing that the isolated cDNA en- 
codes authentic SRP68. 
Using Northern blot analysis on mRNA from MDCK 
cells we estimated the size of the full length mRNA for 
SRP68 to be about 2.5 kb (Fig. 2). Thus pTEX-SRP68- 
II.6 contains a SRP68 cDNA of nearly full length. 
3.2. Expression of SRP68 from pGEMSRP68 cDNA 
clones 
In order to obtain more information about the 5 ‘end 
of SRP68 cDNA and the ATG initiation codon we se- 
quenced the 5 ‘ends of the longest SRP68 clones. Se- 
quences at the 5 ‘ends of these clones are shown in Fig. 
3A. Three independent groups of cDNAs were found: 
SRP68-II. 13 has 5 more bp at its 5 ‘end whereas SRP68- 
II.15 and II.23 lack 13 and 14 bp respectively. SRP68- 
II.15 and -11.23 also lack the first ATG codon. As the 
first ATG codon could be the initiating methionine 
codon we tested whether all or only the two longest of 
these clones encode full length SRP68. pGEM-SRP68 
clones were transcribed from either the SP6 or the T7 
promoter located at the S’side of the respective cDNA 
insert. As shown in Fig. 3B (lanes 6 and 13) only the 
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Fig. 1 Outline and sequence of cDNA pSRP68-II.6 coding for the 68 kDa protein of SRP (SRP68) (A) Outline and partial restriction map of 
pSRP68-11.6. The grey box indicates the coding region of the cDNA for SRP68, the white box a short open reading frame at the 3’end of pSRP68. 
T7: indicates the T7 promoter. The following restriction sites are indicated: NotI, EcoRI, SphI, Psi1 and SmaI. (B) DNA sequence and deduced 
amino acid sequence of the insert in pTEX-SRP68-11.6. Amino acid sequences determined by peptide sequence analysis are underlined. Gaps in- 
dicate amino acids that were not assigned by the direct sequencing of peptides derived from the SRP68. 
clones which contain the first ATG codon (pSRP68-II.6 
and -11.13) also result in the synthesis of a 68 kDa pro- 
tein. Smaller proteins are synthesized from clones 
pSRP68-II.15 and -11.23 suggesting that some initiation 
has occurred at internal codons (Fig. 3B, lanes 15 and 
23). The 68 kDa protein resulting from transcrip- 
tion/translation of clones pSRP68-11.6 and -11.13 can 
specifically be immunoprecipitated with an antiserum 
105 
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1 2 
-18s 
-16s 
Fig. 2 Northern blot analysis of polyA+RNA from MDCK cells (lane 
2) or of ribosomal RNA from canine pancreas (lane 1) using labeled 
pSRP68-II.6 as a probe. 
A 
mat ala ala g1u lys ghl... 
pSRP68-II.6 GGCAAG ATG GCT GCC GAG AAA CAG... 
pSRp68-II.13 GCTGGGGCAAG ATG GCT GCC GAG AAA CAG... 
pSRP68-II.15 CC GAG AAA CAG... 
pSP.P68-II.23 C GAG AAA CAG... 
B 
pSRP6811 fs 
6 13 15 23 
MW 
x 10-3 
-92 
-69 
SRP 
-68 
-46 
Fig. 3(A) DNA sequences of the S’ends of 4 independent SRP68 
cDNA clones. Note that two of these clones lack the presumed ATG 
initiator methionine codon (bold type). (B) In vitro translation of 
mRNA transcribed from the clones outlined in A. Labeled proteins 
were separated by SDS-polyacrylamide gel electrophoresis and 
visualized by fluorography. Numbers on top of the lanes indicate in- 
dividual clones, pSRP68-11.6, -11.13, 11.15, 11.23. Labeled proteins 
from the transcription/translation of pSRP68-II.6 were im- 
munoprecipitated with a rabbit antiserum against SRP68 (anti 
SRP68) or with a non-immune rabbit serum (NRS). The position of 
authentic SRP68 protein from canine pancreas is indicated on the 
right hand side. 
raised against he SRP68 protein. This is shown for the 
pSRP68-II.6 derived protein in Fig. 3B, and adds fur- 
ther proof to the authenticity of the cloned cDNAs. We 
have not further explored the significance of the short 
open reading frame present in the 3 ’ untranslated region 
of the SRP68-mRNA. No significant homologies to 
other proteins in the PIR/Swiss-Prot. databases were 
found. 
4. DISCUSSION 
We have cloned and characterized by sequence 
analysis a cDNA clone encoding the SRP68 protein. 
Two lines of evidence show that its corresponding 
mRNA in fact encodes the SRP68 protein: (i) Peptide 
sequences obtained from the canine pancreas SRP68 
protein match the protein sequence deduced from 
pSRP68-II.6 in 64 out of the 66 amino acid residues 
determined. The two differently assigned residues 
might be due to the different sources of the protein and 
the mRNA used in the analysis, canine pancreas and 
MDCK cells respectively. (ii) Antibodies directed 
against the canine SRP68 specifically recognize the 68 
kDa protein obtained after transcription/translation 
from pSRP68-11.6. Two independent cDNA clones, 
pSRP68-II.6 and -11.13 encode a 68 kDa protein. 
Clones lacking the first ATG codon encode proteins 
with lower molecular weights (Fig. 3B). Thus the first 
ATG codon in pSRP68-II.6 and -11.13 is most likely the 
initiating codon for the 68 kDa SRP protein. However 
as the resolution of SDS gels would not resolve a dif- 
ference of a few amino acids in the molecular mass 
range of 70 kDa we cannot completely rule out initia- 
tion at a more upstream ATG. Assuming initiation to 
occur at the first ATG in pSRP68-II.6 and -11.13, 
SRP68 comprizes 622 amino acid residues and has a 
calculated h4, of 70.2. This is in good agreement with 
the apparent molecular mass of 68 kDa as determined 
by SDS-PAGE. SRP68 is a polar protein with an overall 
basic character (estimated p1 of 8.79). The amino acid 
sequence does not show significant similarity to any of 
the sequences in the Swiss-Prot., NBRF, EMBL or 
Brookhaven sequence library. The glycine-rich region 
close to the N-terminus of SRP68 is a notable feature. 
A similar region is also found in a heterogeneous 
nuclear RNP protein [23], a U3 small nuclear 
ribonucleoprotein [24], a helix destabilizing protein [25] 
and some cell wall proteins [26]. Although the func- 
tional significance of the N-terminal polyglycine region 
is not known, it is remarkable, that all the glycine 
residues within that region are coded for by the same 
codon (GGC), whereas the ones flanking the stretch are 
encoded by GGT and GGG respectively. This is a 
characteristic feature of the variable number of tandem 
repeats found widely distributed throughout the mam- 
malian genome [32]. 
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SRP68 interacts with the SRP72 protein in authentic 
SRP [9,11]. This became evident from disassembly of 
SRP into its RNA and protein components. SRP68 and 
the SRP72 can be released from SRP as a heterodimeric 
complex (SRP68/72) under two different conditions: in 
2 M KC1 and in the presence of EDTA and DE53 
cellulose resin [9,11]. Thus the SRP68 must interact 
with the SRP72. The SRP68/72 complex can directly 
interact with SRP7S RNA and fragments generated by 
cleavage of the SRP68 with elastase were not released 
from the particle [9,11]. It therefore has been tentative- 
ly concluded, that the SRP68 anchors the SRP68/72 
complex to the particle and that the SRP68 might 
directly interact with SRP7S RNA [9]. Thus two func- 
tions of the SRP68 can be distinguished, binding to the 
SRP72 protein and possibly to SRP7S RNA [9]. 
Methods for binding of in vitro synthesized SRP pro- 
teins to SRP7S RNA have been established [12,27,28]. 
Attempts to bind in vitro synthesized SRP68 to SRP7S 
RNA by a previously described method [27] failed 
(Rdmisch, unpublished). This could indicate that the 
formation of the SRP68/72 heterodimer is a prere- 
quisite for binding to SRP7S RNA. Dimer formation 
between the SRP9 and SRP14 protein was found to be 
required for their interaction with SRP7S RNA [28]. 
Alternatively a modification of the SRP68 could be 
necessary that is not obtained in the in vitro cell-free 
system. 
Only a few sequence lements that interact with RNA 
have been characterized to date. The best characterized 
is the so called RNP consensus sequence (RNP-CS) 
[29,30]. This is a conserved stretch of 8 amino acids 
within a putative RNA binding domain of 80-90 amino 
acid residues [29]. No such region is found in the se- 
quence of the SRP68. A detailed functional analysis of 
this protein will require the isolation of cDNA coding 
for the SRP72 protein with which SRP68 interacts in 
the SRP and with which it may form a functional com- 
plex. 
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